Cargando…
Immune Checkpoint Blockade – How Does It Work in Brain Metastases?
Immune checkpoints restrain the immune system following its activation and their inhibition unleashes anti-tumor immune responses. Immune checkpoint inhibitors revolutionized the treatment of several cancer types, including melanoma, and immune checkpoint blockade with anti-PD-1 and anti-CTLA-4 anti...
Autores principales: | Lorger, Mihaela, Andreou, Tereza, Fife, Christopher, James, Fiona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881300/ https://www.ncbi.nlm.nih.gov/pubmed/31824260 http://dx.doi.org/10.3389/fnmol.2019.00282 |
Ejemplares similares
-
Biglycan and reduced glycolysis are associated with breast cancer cell dormancy in the brain
por: Sunderland, Ashley, et al.
Publicado: (2023) -
Efficacy and safety of immune checkpoint blockade for brain metastases
por: Harary, Maya, et al.
Publicado: (2019) -
Metastatic site-specific polarization of macrophages in intracranial breast cancer metastases
por: Rippaus, Nora, et al.
Publicado: (2016) -
Hematopoietic Stem Cell Gene Therapy for Brain Metastases Using Myeloid Cell–Specific Gene Promoters
por: Andreou, Tereza, et al.
Publicado: (2019) -
Mismatch repair–deficient prostate cancer with parenchymal brain metastases treated with immune checkpoint blockade
por: Sena, Laura A., et al.
Publicado: (2021)